In Vitro Models of IBD
Unlock Insights into IBD Research with Our In Vitro Models of IBD Case Study
Explore how Ace Therapeutics accelerates IBD research with co-culture model of NCM460/THP-1 cells and intestinal organoids model. This poster offers an in-depth case study and showcases our capabilities in modeling complex immune and epithelial interactions critical to IBD pathology. Discover how our platform can support your preclinical programs with data-driven confidence.
Step-by-Step Protocol Transparency
From cell culture and immune differentiation (e.g., PMA-induced THP-1 macrophages) to co-culture timelines and treatment regimens, each step is standardized for consistency and reproducibility.
Strict and Multimodal Validation Data
Focuses on core experimental outcomes, providing directly applicable empirical support for protocol design:
- Morphology observation of organoids: In our intestinal organoid model, morphology observation provides critical visual confirmation of structural integrity and responsiveness to treatment.
- Barrier integrity assessment: TEER measurement and tight junction protein staining (e.g., ZO-1 via immunofluorescence) quantify epithelial barrier function and disruption.